quantitative
Analysis v1
Strong Support
A drug called retatrutide probably helps people with obesity or type 2 diabetes lose about 14% of their body weight when given as a weekly shot for up to a year, and higher doses seem to lead to more weight loss.
57
0
Evidence from Studies
Supporting (1)
57
Community contributions welcome
57
Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomized controlled trials
Systematic Review With Meta-Analysis
Human
2025The study looked at the same drug, dose, and patients as the claim and found the same amount of weight loss, with better results at higher doses.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.